CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $936,340 | -4.4% | 103,463 | +13.6% | 0.00% | – |
Q2 2023 | $979,881 | -5.2% | 91,067 | -9.9% | 0.00% | – |
Q1 2023 | $1,033,761 | -0.2% | 101,052 | +3.0% | 0.00% | – |
Q4 2022 | $1,035,514 | -11.3% | 98,153 | +7.8% | 0.00% | -100.0% |
Q3 2022 | $1,167,000 | -0.8% | 91,067 | -0.8% | 0.00% | – |
Q2 2022 | $1,176,000 | -10.0% | 91,776 | -26.5% | 0.00% | – |
Q1 2022 | $1,307,000 | +289.0% | 124,909 | +474.5% | 0.00% | – |
Q4 2021 | $336,000 | +273.3% | 21,742 | +444.5% | 0.00% | – |
Q3 2021 | $90,000 | +80.0% | 3,993 | +103.1% | 0.00% | – |
Q2 2021 | $50,000 | -61.2% | 1,966 | -36.4% | 0.00% | – |
Q1 2021 | $129,000 | – | 3,093 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |